The Prolactin Serum Test measures the level of prolactin hormone in the blood, assessing pituitary gland function and hormonal balance.

It is used to diagnose pituitary disorders, investigate unexplained symptoms, evaluate hormonal imbalances, and monitor treatment for related conditions.

Fasting is not required, but avoid a large meal before the test. Inform your healthcare provider about any medications or supplements.

Results are typically available within 1 to 3 days after the test.

It can help diagnose conditions such as prolactinomas, hormonal imbalances, hypothyroidism, and other endocrine disorders affecting prolactin levels.

CRRT is a medical therapy used in intensive care units to manage patients with acute kidney injury (AKI) or severe kidney dysfunction. It involves the continuous removal of waste products and excess fluids from the blood.

CRRT is used when a patient’s kidneys are unable to adequately filter waste and excess fluids from the blood, leading to dangerous levels of toxins and fluid overload.

CRRT differs from hemodialysis in that it is slower and performed continuously over 24 hours or longer periods. Hemodialysis, on the other hand, is intermittent and typically lasts for a few hours.

Yes, CRRT can be used cautiously in patients with heart failure to manage fluid overload and electrolyte imbalances, with careful monitoring of hemodynamic status.

CRRT provides gentler and more gradual fluid and solute removal, making it suitable for hemodynamically unstable patients who cannot tolerate the rapid changes associated with conventional hemodialysis.

The surgery typically takes 1 to 2 hours, depending on the complexity of the fracture and the surgical approach.